Histiocytosis and the nervous system: from diagnosis to targeted therapies.

Abstract

Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation of CD68(+) cells with various admixed inflammatory infiltrates. The identification of the pivotal role of the mitogen-activated protein kinase (MAPK) pathway has opened new avenues of research and therapeutic approaches. We review the neurologic manifestations of 3 histiocytic disorders with frequent involvement of the brain and spine: Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), and Rosai-Dorfman-Destombes disease (RDD). Central nervous system (CNS) manifestations occur in 10%-25% of LCH cases, with both tumorous or neurodegenerative forms. These subtypes differ by clinical and radiological presentation, pathogenesis, and prognosis. Tumorous or degenerative neurologic involvement occurs in 30%-40% of ECD patients and affects the hypothalamic-pituitary axis, meninges, and brain parenchyma. RDD lesions are typically tumorous with meningeal or parenchymal masses with strong contrast enhancement. Unlike LCH and ECD, neurodegenerative lesions or syndromes have not been described with RDD. Familiarity with principles of evaluation and treatment both shared among and distinct to each of these 3 diseases is critical for effective management. Refractory or disabling neurohistiocytic involvement should prompt the consideration for use of targeted kinase inhibitor therapies.

• Authors: Fleur Cohen Aubart, Ahmed Idbaih, Jean-François Emile, Zahir Amoura, Omar Abdel-Wahab, Benjamin H Durham, Julien Haroche, Eli L Diamond
• Journal: Neuro-oncology (Neuro Oncol) Vol. 23 Issue 9 Pg. 1433-1446 (09 01 2021) ISSN: 1523-5866 [Electronic] England
• PMID: 33993305 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
• Copyright: © The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.

Topics

• Central Nervous System
• Erdheim-Chester Disease (diagnosis, drug therapy)
• Histiocytosis, Langerhans-Cell (diagnosis, drug therapy)
• Histiocytosis, Sinus
• Humans
• Prognosis